Efficacy and Safety of Atenas Association in the Treatment of Type II Diabetes Mellitus and Hypertension

PHASE3WithdrawnINTERVENTIONAL
0
Timeline

Start Date

August 31, 2022

Primary Completion Date

July 31, 2024

Study Completion Date

November 30, 2024

Conditions
Hypertension AssociatedType II Diabetes Mellitus
Interventions
DRUG

Atenas

ATENAS 1 coated tablet, once a day EMPAGLIFLOZIN PLACEBO Empagliflozin placebo 1 coated tablet, once a day TELMISARTAN + AMLODIPINE PLACEBO Telmisartan + amlodipine 1 coated tablet, once a day

DRUG

Atenas placebo

Drug: EMPAGLIFLOZIN Empagliflozin 25 mg 1 coated tablet, once a day. Drug: TELMISARTAN Telmisartan + Amlodipine 40 + 5/80 +5 mg 1 coated tablet, once a day ATENAS PLACEBO Atenas placebo 1 coated tablet, once a day

Sponsors

Lead Sponsor

All Listed Sponsors
lead

EMS

INDUSTRY